Alexandra Helleux

4PUBLICATIONS
34CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Mar 28, 2025
TFE3 fusions drive oxidative metabolism and ferroptosis resistance in translocation renal cell carcinoma.

Alexandra Helleux, Guillaume Davidson, Antonin Lallement

|May 26, 2023
SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance.

Bujamin H Vokshi, Guillaume Davidson, Nassim Tawanaie Pour Sedehi

|Nov 14, 2022
An Enhancer Demethylator Phenotype Converged to Immune Dysfunction and Resistance to Immune Checkpoint Inhibitors in Clear-Cell Renal Cell Carcinomas.

Xiaofan Lu, Yann Vano, Alexandra Helleux

Pageof 1